Association of ERCC1 protein expression to platinum resistance in epithelial ovarian cancer

被引:0
|
作者
Steffensen, K. D. [1 ]
Waldstrom, M. [1 ]
Jakobsen, A. [1 ]
机构
[1] Vejle Hosp, Vejle, Denmark
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5530
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Evaluation of expression of ERCC1 in hepatocellular cancer
    Bas, E.
    Turhal, N. S.
    Er, O.
    Aliustaoglu, M.
    Seber, S.
    Dane, F.
    Korkmaz, T.
    Soyuer, I.
    Ozkara, S.
    Celikel, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [32] Meta-analysis of excision repair cross complementary gene 1 (ERCC1) expression and platinum chemosensitivity in patients with ovarian cancer
    Wu, Jiaohong
    Li, Renliang
    Chen, Xinyan
    Chen, Cong
    Chen, Haitang
    Ma, Bidong
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (05) : 3428 - 3435
  • [33] Meta-Analysis of ERCC1 Protein Expression and Platinum Chemosensitivity in Non-Small-Cell Lung Cancer
    Li, Guoping
    Cheng, Dan
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2020, 2020
  • [34] Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody
    David Hersi Smith
    Anne-Marie Kanstrup Fiehn
    Louise Fogh
    Ib Jarle Christensen
    Tine Plato Hansen
    Jan Stenvang
    Hans Jørgen Nielsen
    Kirsten Vang Nielsen
    Jane Preuss Hasselby
    Nils Brünner
    Sussie Steen Jensen
    Scientific Reports, 4
  • [35] Immunofluorescent analysis and estimation of clinical significance of ERCC1 expression in ovarian cancer tissue
    Semakov, A. V.
    Bogush, T. A.
    Dudko, E. A.
    Grishanina, A. N.
    Tjulandina, A. S.
    Tjulandin, S. A.
    Zarkua, V. T.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S129 - S130
  • [36] ERCC1 AND ERCC2 EXPRESSION IN MALIGNANT-TISSUES FROM OVARIAN-CANCER PATIENTS
    DABHOLKAR, M
    BOSTICKBRUTON, F
    WEBER, C
    BOHR, VA
    EGWUAGU, C
    REED, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (19) : 1512 - 1517
  • [37] Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancer
    Scurry, James
    van Zyl, Belinda
    Gulliver, Damien
    Otton, Geoffrey
    Jaaback, Kenneth
    Lombard, Janine
    Vilain, Ricardo E.
    Bowden, Nikola A.
    GYNECOLOGIC ONCOLOGY, 2018, 151 (02) : 306 - 310
  • [38] FSP1 expression as a predictor of platinum resistance and recurrence in epithelial ovarian cancer
    Xing, Hang
    Bi, Hai-Ning
    Yin, Qi
    Zhang, Ji
    Zhang, Xue
    Li, Yao-Jiao
    Gong, Xue-Mei
    Shi, Ji-Fang
    ANTI-CANCER DRUGS, 2025, 36 (04) : 338 - 346
  • [39] Measuring ERCC1 protein expression in cancer specimens: Validation of a novel antibody
    Smith, David Hersi
    Fiehn, Anne-Marie Kanstrup
    Fogh, Louise
    Christensen, Ib Jarle
    Hansen, Tine Plato
    Stenvang, Jan
    Nielsen, Hans Jorgen
    Nielsen, Kirsten Vang
    Hasselby, Jane Preuss
    Brunner, Nils
    Jensen, Sussie Steen
    SCIENTIFIC REPORTS, 2014, 4
  • [40] ERCC1 expression in triple negative breast cancer
    Ozkan, C.
    Gumuskaya, B.
    Yaman, S.
    Aksoy, S.
    Guler, G.
    Altundag, K.
    JOURNAL OF BUON, 2012, 17 (02): : 271 - 276